Metabolic profiling in diabetes

Journal of Endocrinology

Volumn 221, Issue 3, 2014, Pages

  Suhre, Karsten ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (Qatar)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Diabetes; Glucose metabolism; Insulin resistance; Lipid; Metabolism

Indexed keywords

ANTIDIABETIC AGENT; BIOLOGICAL MARKER;

CROSS-SECTIONAL STUDY; DATA ANALYSIS; DIABETES MELLITUS; DRUG EFFICACY; DRUG TARGETING; GENETIC VARIABILITY; HUMAN; MEDICAL RESEARCH; METABOLOMICS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; STUDY DESIGN;

DIABETES; GLUCOSE METABOLISM; INSULIN RESISTANCE; LIPID; METABOLISM;

BIOLOGICAL MARKERS; DIABETES MELLITUS; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; METABOLIC NETWORKS AND PATHWAYS; METABOLOME; METABOLOMICS;

EID: 84901592466     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-14-0024     Document Type: Review

References (85)

1. Aharoni A, Ric de Vos CH, Verhoeven HA, Maliepaard CA, Kruppa G, Bino R & Goodenowe DB 2002 Nontargeted metabolome analysis by use of Fourier Transform Ion Cyclotron Mass Spectrometry. OMICS 6 217-234. (doi:10.1089/15362310260256882)
2. Almgren P, Lehtovirta M, Isomaa B, Sarelin L, Taskinen MR, Lyssenko V, Tuomi T & Groop L 2011 Heritability and familiality of type 2 diabetes and related quantitative traits in the Botnia Study. Diabetologia 54 2811-2819. (doi:10.1007/s00125-011-2267-5)
3. Altmaier E, Ramsay SL, Graber A, Mewes HW, Weinberger KM & Suhre K 2008 Bioinformatics analysis of targeted metabolomics - uncovering old and new tales of diabetic mice under medication. Endocrinology 149 3478-3489. (doi:10.1210/en.2007-1747)
4. Aulchenko YS, Ripatti S, Lindqvist I, Boomsma D, Heid IM, Pramstaller PP, Penninx BW, Janssens AC, Wilson JF, Spector T et al. 2009 Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nature Genetics 41 47-55. (doi:10.1038/ng.269)
5. Bain JR, Stevens RD, Wenner BR, Ilkayeva O, Muoio DM & Newgard CB 2009 Metabolomics applied to diabetes research: moving from information to knowledge. Diabetes 58 2429-2443. (doi:10.2337/db09-0580)
6. Batch BC, Hyland K & Svetkey LP 2014 Branch chain amino acids:biomarkers of health and disease. Current Opinion in Clinical Nutrition and Metabolic Care 17 86-89. (doi:10.1097/MCO.0000000000000010)
7. Bouatra S, Aziat F, Mandal R, Guo AC, Wilson MR, Knox C, Bjorndahl TC, Krishnamurthy R, Saleem F, Liu P et al. 2013 The human urine metabolome. PLoS ONE 8 e73076. (doi:10.1371/journal.pone.0073076)
8. Cobb J, Gall W, Adam KP, Nakhle P, Button E, Hathorn J, Lawton K, Milburn M, Perichon R, Mitchell M et al. 2013 A novel fasting blood test for insulin resistance and prediabetes. Journal of Diabetes Science and Technology 7 100-110. (doi:10.1177/193229681300700112)
9. Deo RC, Hunter L, Lewis GD, Pare G, Vasan RS, Chasman D, Wang TJ, Gerszten RE & Roth FP 2010 Interpreting metabolomic profiles using unbiased pathway models. PLoS Computational Biology 6 e1000692. (doi:10.1371/journal.pcbi.1000692)
10. Drong AW, Lindgren CM & McCarthy MI 2012 The genetic and epigenetic basis of type 2 diabetes and obesity. Clinical Pharmacology and Therapeutics 92 707-715. (doi:10.1038/clpt.2012.149)
11. Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, Jackson AU, Wheeler E, Glazer NL, Bouatia-Naji N, Gloyn AL et al. 2010 New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nature Genetics 42 105-116. (doi:10.1038/ng.520)
12. Evans AM, DeHaven CD, Barrett T, Mitchell M & Milgram E 2009 Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. Analytical Chemistry 81 6656-6667. (doi:10.1021/ac901536h)
13. Faresjo T & Faresjo A 2010 To match or not to match in epidemiological studies - same outcome but less power. International Journal of Environmental Research and Public Health 7 325-332. (doi:10.3390/ijerph7010325)
14. Ferrannini E, Natali A, Camastra S, Nannipieri M, Mari A, Adam KP, Milburn MV, Kastenmuller G, Adamski J, Tuomi T et al. 2013 Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance. Diabetes 62 1730-1737. (doi:10.2337/db12-0707)
15. Fiehn O 2002 Metabolomics - the link between genotypes and phenotypes. Plant Molecular Biology 48 155-171. (doi:10.1023/A:1013713905833)
16. Fiehn O, Garvey WT, Newman JW, Lok KH, Hoppel CL & Adams SH 2010 Plasma metabolomic profiles reflective of glucose homeostasis in non-diabetic and type 2 diabetic obese African-American women. PLoS ONE 5 e15234. (doi:10.1371/journal.pone.0015234)
17. Fliniaux O, Gaillard G, Lion A, Cailleu D, Mesnard F & Betsou F 2011 Influence of common preanalytical variations on the metabolic profile of serum samples in biobanks. Journal of Biomolecular NMR 51 457-465. (doi:10.1007/s10858-011-9574-5)
18. Floegel A, Stefan N, Yu Z, Muhlenbruch K, Drogan D, Joost HG, Fritsche A, Haring HU, Hrabe de Angelis M, Peters A et al. 2013 Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes 62 639-648. (doi:10.2337/db12-0495)
19. Frayling TM, Timpson NJ,Weedon MN, Zeggini E, Freathy RM, Lindgren CM, Perry JR, Elliott KS, Lango H, Rayner NW et al. 2007 A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316 889-894. (doi:10.1126/science. 1141634)
20. Friedrich N 2012 Metabolomics in diabetes research. Journal of Endocrinology 215 29-42. (doi:10.1530/JOE-12-0120)
21. Friedrich N, Budde K, Wolf T, Jungnickel A, Grotevendt A, Dressler M, Volzke H, Bluher M, Nauck M, Lohmann T et al. 2012 Short-term changes of the urine metabolome after bariatric surgery. OMICS 16 612-620. (doi:10.1089/omi.2012.0066)
22. Gall WE, Beebe K, Lawton KA, Adam KP,Mitchell MW, Nakhle PJ, Ryals JA, Milburn MV, Nannipieri M, Camastra S et al. 2010 a-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population. PLoS ONE 5 e10883. (doi:10.1371/journal.pone.0010883)
23. German JB, Hammock BD & Watkins SM 2005 Metabolomics: building on a century of biochemistry to guide human health. Metabolomics 1 3-9. (doi:10.1007/s11306-005-1102-8)
24. Gieger C, Geistlinger L, Altmaier E, Hrabe de Angelis M, Kronenberg F, Meitinger T, Mewes HW, Wichmann HE, Weinberger KM, Adamski J et al. 2008 Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum. PLoS Genetics 4 e1000282. (doi:10.1371/journal.pgen.1000282)
25. de Graaf MA, Jager KJ, Zoccali C & Dekker FW 2011 Matching, an appealing method to avoid confounding? Nephron. Clinical Practice 118 c315-c318. (doi:10.1159/000323136)
26. Griffin JL, Williams HJ, Sang E, Clarke K, Rae C & Nicholson JK 2001 Metabolic profiling of genetic disorders: a multitissue 1H nuclear magnetic resonance spectroscopic and pattern recognition study into dystrophic tissue. Analytical Biochemistry 293 16-21. (doi:10.1006/abio.2001.5096)
27. Groop LC 1992 Sulfonylureas in NIDDM. Diabetes Care 15 737-754. (doi:10.2337/diacare.15.6.737)
28. Hirose H, Kawai T, Yamamoto Y, Taniyama M, Tomita M, Matsubara K, Okazaki Y, Ishii T, Oguma Y, Takei I et al. 2002 Effects of pioglitazone on metabolic parameters, body fat distribution, and serum adiponectin levels in Japanese male patients with type 2 diabetes. Metabolism:Clinical and Experimental 51 314-317. (doi:10.1053/meta.2002.30506)
29. Ho JE, Larson MG, Vasan RS, Ghorbani A, Cheng S, Rhee EP, Florez JC, Clish CB, Gerszten RE & Wang TJ 2013 Metabolite profiles during oral glucose challenge. Diabetes 62 2689-2698. (doi:10.2337/db12-0754)
30. Hundal RS, Krssak M, Dufour S, Laurent D, Lebon V, Chandramouli V, Inzucchi SE, Schumann WC, Petersen KF, Landau BR et al. 2000 Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes 49 2063-2069. (doi:10.2337/diabetes.49.12.2063)
31. Ibanez AJ, Fagerer SR, Schmidt AM, Urban PL, Jefimovs K, Geiger P, Dechant R, Heinemann M & Zenobi R 2013 Mass spectrometry-based metabolomics of single yeast cells. PNAS 110 8790-8794. (doi:10.1073/pnas.1209302110)
32. Illig T, Gieger C, Zhai G, Romisch-Margl W, Wang-Sattler R, Prehn C, Altmaier E, Kastenmuller G, Kato BS, Mewes HW et al. 2010 A genomewide perspective of genetic variation in human metabolism. Nature Genetics 42 137-141. (doi:10.1038/ng.507)
33. Kaddurah-Daouk R, Kristal BS & Weinshilboum RM 2008 Metabolomics:a global biochemical approach to drug response and disease. Annual Review of Pharmacology and Toxicology 48 653-683. (doi:10.1146/annurev.pharmtox.48.113006.094715)
34. Kathiresan S, Melander O, Guiducci C, Surti A, Burtt NP, Rieder MJ, Cooper GM, Roos C, Voight BF, Havulinna AS et al. 2008 Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nature Genetics 40 189-197. (doi:10.1038/ng.75)
35. Kim WJ, Park CY, Lee KB, Park SE, Rhee EJ, Lee WY, Oh KW & Park SW 2012 Serum 1,5-anhydroglucitol concentrations are a reliable index of glycemic control in type 2 diabetes with mild or moderate renal dysfunction. Diabetes Care 35 281-286. (doi:10.2337/dc11-1462)
36. Kottgen A, Pattaro C, Boger CA, Fuchsberger C, Olden M,Glazer NL, Parsa A, Gao X, Yang Q, Smith AV et al. 2010 New loci associated with kidney function and chronic kidney disease. Nature Genetics 42 376-384. (doi:10.1038/ng.568)
37. Kraja AT, Vaidya D, Pankow JS, Goodarzi MO, Assimes TL, Kullo IJ, Sovio U, Mathias RA, Sun YV, Franceschini N et al. 2011 A bivariate genomewide approach to metabolic syndrome: STAMPEED consortium. Diabetes 60 1329-1339. (doi:10.2337/db10-1011)
38. Kronenberg F 2012 Metabolic traits as intermediate phenotypes. In Genetics Meets Metabolomics: from Experiment to Systems Biology, Ed. K Suhre. New York, Heidelberg, Dordrecht, London: Springer.
39. Krug S, Kastenmuller G, Stuckler F, Rist MJ, Skurk T, Sailer M, Raffler J, Romisch-Margl W, Adamski J, Prehn C et al. 2012 The dynamic range of the human metabolome revealed by challenges. FASEB Journal 26 2607-2619. (doi:10.1096/fj.11-198093)
40. Krumsiek J, Suhre K, Illig T, Adamski J & Theis FJ 2011 Gaussian graphical modeling reconstructs pathway reactions from high-throughput metabolomics data. BMC Systems Biology 5 21. (doi:10.1186/1752-0509-5-21)
41. Krumsiek J, Suhre K, Evans AM, Mitchell MW, Mohney RP, Milburn MV, Wagele B, Romisch-Margl W, Illig T, Adamski J et al. 2012 Mining the unknown: a systems approach to metabolite identification combining genetic and metabolic information. PLoS Genetics 8 e1003005. (doi:10.1371/journal.pgen.1003005)
42. Maher B 2008 Personal genomes: the case of themissing heritability. Nature 456 18-21. (doi:10.1038/456018a)
43. Martin FP, Dumas ME, Wang Y, Legido-Quigley C, Yap IK, Tang H, Zirah S, Murphy GM, Cloarec O, Lindon JC et al. 2007 A top-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model. Molecular Systems Biology 3 112. (doi:10.1038/msb4100153)
44. Menni C, Fauman E, Erte I, Perry JR, Kastenmuller G, Shin SY, Petersen AK, Hyde C, Psatha M, Ward KJ et al. 2013 Biomarkers for type 2 diabetes and impaired fasting glucose using a non-targeted metabolomics approach. Diabetes 62 4270-4276. (doi:10.2337/db13-0570)
45. Milburn MV & Lawton KA 2013 Application of metabolomics to diagnosis of insulin resistance. Annual Review of Medicine 64 291-305. (doi:10.1146/annurev-med-061511-134747)
46. Moayyeri A, Hammond CJ, Hart DJ & Spector TD 2013 The UK Adult Twin Registry (Twins UK Resource). Twin Research and Human Genetics 16 144-149. (doi:10.1017/thg.2012.89)
47. Mook-Kanamori DO, El-Din Selim MM, Takiddin AH, Al-Homsi H, Al-Mahmoud KA, Al-Obaidli A, Zirie MA, Rowe J, Yousri NA, Karoly ED et al. 2014 1,5-anhydroglucitol in saliva is a non-invasive marker of short-term glycemic control. Journal of Clinical Endocrinology and Metabolism 99 E479-E483. (doi:10.1210/jc.2013-3596)
48. Newgard CB 2012 Interplay between lipids and branched-chain amino acids in development of insulin resistance. Cell Metabolism 15 606-614. (doi:10.1016/j.cmet.2012.01.024)
49. Newgard CB, An J, Bain JR, Muehlbauer MJ, Stevens RD, Lien LF, Haqq AM, Shah SH, Arlotto M, Slentz CA et al. 2009 A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metabolism 9 311-326. (doi:10.1016/j.cmet.2009.02.002)
50. Ng SF, Lin RC, Laybutt DR, Barres R, Owens JA & Morris MJ 2010 Chronic high-fat diet in fathers programs b-cell dysfunction in female rat offspring. Nature 467 963-966. (doi:10.1038/nature09491)
51. Nicholson JK & Lindon JC 2008 Systems biology: metabonomics. Nature 455 1054-1056. (doi:10.1038/4551054a)
52. Nicholson JK, Lindon JC & Holmes E 1999 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29 1181-1189. (doi:10.1080/004982599238047)
53. Nicholson JK, Connelly J, Lindon JC & Holmes E 2002 Metabonomics:a platform for studying drug toxicity and gene function. Nature Reviews. Drug Discovery 1 153-161. (doi:10.1038/nrd728)
54. Panneerselvam K & Freeze HH 1996 Mannose enters mammalian cells using a specific transporter that is insensitive to glucose. Journal of Biological Chemistry 271 9417-9421. (doi:10.1074/jbc.271.16.9417)
55. Parikh H, Carlsson E, Chutkow WA, Johansson LE, Storgaard H, Poulsen P, Saxena R, Ladd C, Schulze PC, Mazzini MJ et al. 2007 TXNIP regulates peripheral glucose metabolism in humans. PLoS Medicine 4 e158. (doi:10.1371/journal.pmed.0040158)
56. Pauling L, Robinson AB, Teranishi R & Cary P 1971 Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography. PNAS 68 2374-2376. (doi:10.1073/pnas.68.10.2374)
57. Pellis L, van Erk MJ, van Ommen B, Bakker GC, Hendriks HF, Cnubben NH, Kleemann R, van Someren EP, Bobeldijk I, Rubingh CM et al. 2012 Plasma metabolomics and proteomics profiling after a postprandial challenge reveal subtle diet effects on human metabolic status. Metabolomics 8 347-359. (doi:10.1007/s11306-011-0320-5)
58. Petersen AK, Krumsiek J, Wagele B, Theis FJ, Wichmann HE, Gieger C & Suhre K 2012 On the hypothesis-free testing of metabolite ratios in genome-wide and metabolome-wide association studies. BMC Bioinformatics 13 120. (doi:10.1186/1471-2105-13-120)
59. Petersen AK, Zeilinger S, Kastenmuller G, Romisch-Margl W, Brugger M, Peters A, Meisinger C, Strauch K, Hengstenberg C, Pagel P et al. 2014 Epigenetics meets metabolomics: an epigenome-wide association study with blood serum metabolic traits. Human Molecular Genetics 23 534-545. (doi:10.1093/hmg/ddt430)
60. Prokopenko I, Langenberg C, Florez JC, Saxena R, Soranzo N, Thorleifsson G, Loos RJ, Manning AK, Jackson AU, Aulchenko Y et al. 2009 Variants in MTNR1B influence fasting glucose levels. Nature Genetics 41 77-81. (doi:10.1038/ng.290)
61. Renner S, Romisch-Margl W, Prehn C, Krebs S, Adamski J, Goke B, Blum H, Suhre K, Roscher AA & Wolf E 2012 Changing metabolic signatures of amino acids and lipids during the prediabetic period in a pig model with impaired incretin function and reduced b-cell mass. Diabetes 61 2166-2175. (doi:10.2337/db11-1133)
62. Robertson DG & Frevert U 2013 Metabolomics in drug discovery and development. Clinical Pharmacology and Therapeutics 94 559-561. (doi:10.1038/clpt.2013.120)
63. Shaham O, Wei R, Wang TJ, Ricciardi C, Lewis GD, Vasan RS, Carr SA, Thadhani R, Gerszten RE & Mootha VK 2008 Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity. Molecular Systems Biology 4 214. (doi:10.1038/msb.2008.50)
64. Shin SY, Fauman EB, Petersen AK, Krumsiek J, Santos R, Huang J, Arnold M, Erte I, Forgetta V, Yang TP, et al. (In Press) An atlas of genetic influences on human blood metabolites. Nature Genetics.
65. Suhre K & Gieger C 2012 Genetic variation in metabolic phenotypes: study designs and applications. Nature Reviews. Genetics 13 759-769. (doi:10.1038/nrg3314)
66. Suhre K, Meisinger C, Doring A, Altmaier E, Belcredi P, Gieger C, Chang D, Milburn MV, Gall WE, Weinberger KM et al. 2010 Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting. PLoS ONE 5 e13953. (doi:10.1371/journal.pone.0013953)
67. Suhre K, Romisch-Margl W, de Angelis MH, Adamski J, Luippold G & Augustin R 2011a Identification of a potential biomarker for FABP4 inhibition: the power of lipidomics in preclinical drug testing. Journal of Biomolecular Screening 16 467-475. (doi:10.1177/1087057111402200)
68. Suhre K, Shin SY, Petersen AK, Mohney RP, Meredith D, Wagele B, Altmaier E, Deloukas P, Erdmann J, Grundberg E et al. 2011b Human metabolic individuality in biomedical and pharmaceutical research. Nature 477 54-60. (doi:10.1038/nature10354)
69. Taguchi T, Yamashita E, Mizutani T, Nakajima H, Yabuuchi M, Asano N & Miwa I 2005 Hepatic glycogen breakdown is implicated in the maintenance of plasma mannose concentration. American Journal of Physiology. Endocrinology and Metabolism 288 E534-E540. (doi:10.1152/ajpendo.00451.2004)
70. Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, Koseki M, Pirruccello JP, Ripatti S, Chasman DI, Willer CJ et al. 2010 Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466 707-713. (doi:10.1038/nature09270)
71. Wahl S, Krug S, Then C, Kirchhofer A, Kastenmüller G, Brand T, Skurk T, Claussnitzer M, Huth C, Heier M et al. 2014 Comparative analysis of plasma metabolomics response to metabolic challenge tests in healthy subjects and influence of the FTO obesity risk allele. Metabolomics 10 386-401. (doi:10.1007/s11306-013-0586-x)
72. Wang C, Kong H, Guan Y, Yang J, Gu J, Yang S & Xu G 2005 Plasma phospholipid metabolic profiling and biomarkers of type 2 diabetes mellitus based on high-performance liquid chromatography/electrospray mass spectrometry and multivariate statistical analysis. Analytical Chemistry 77 4108-4116. (doi:10.1021/ac0481001)
73. Wang TJ, Larson MG, Vasan RS, Cheng S, Rhee EP, McCabe E, Lewis GD, Fox CS, Jacques PF, Fernandez C et al. 2011 Metabolite profiles and the risk of developing diabetes. Nature Medicine 17 448-453. (doi:10.1038/nm.2307)
74. Wang TJ, Ngo D, Psychogios N, Dejam A, Larson MG, Vasan RS, Ghorbani A, O'Sullivan J, Cheng S, Rhee EP et al. 2013 2-Aminoadipic acid is a biomarker for diabetes risk. Journal of Clinical Investigation 123 4309-4317. (doi:10.1172/JCI64801)
75. Wang-Sattler R, Yu Z, Herder C, Messias AC, Floegel A, He Y, Heim K, Campillos M, Holzapfel C, Thorand B et al. 2012 Novel biomarkers for pre-diabetes identified by metabolomics. Molecular Systems Biology 8 615. (doi:10.1038/msb.2012.43)
76. Watkins SM, Reifsnyder PR, Pan HJ, German JB & Leiter EH 2002 Lipid metabolome-wide effects of the PPARg agonist rosiglitazone. Journal of Lipid Research 43 1809-1817. (doi:10.1194/jlr.M200169-JLR200)
77. Watts G 2012 UK Biobank opens it data vaults to researchers. BMJ 344 e2459. (doi:10.1136/bmj.e2459)
78. Weljie AM, Newton J, Mercier P, Carlson E & Slupsky CM 2006 Targeted profiling: quantitative analysis of 1H NMR metabolomics data. Analytical Chemistry 78 4430-4442. (doi:10.1021/ac060209g)
79. Wenk MR 2005 The emerging field of lipidomics. Nature Reviews. Drug Discovery 4 594-610. (doi:10.1038/nrd1776)
80. Wichmann HE, Gieger C & Illig T 2005 KORA-gen - resource for population genetics, controls and a broad spectrum of disease phenotypes. Gesundheitswesen 67(Suppl 1) S26-S30. (doi:10.1055/s-2005-858226)
81. Wishart DS, Jewison T, Guo AC, Wilson M, Knox C, Liu Y, Djoumbou Y, Mandal R, Aziat F, Dong E et al. 2013 HMDB 3.0 - The Human Metabolome Database in 2013. Nucleic Acids Research 41 D801-D807. (doi:10.1093/nar/gks1065)
82. WTCCC 2007 Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447 661-678. (doi:10.1038/nature05911)
83. Würtz P, Makinen VP, Soininen P, Kangas AJ, Tukiainen T, Kettunen J, Savolainen MJ, Tammelin T, Viikari JS, Ronnemaa T et al. 2012 Metabolic signatures of insulin resistance in 7,098 young adults. Diabetes 61 1372-1380. (doi:10.2337/db11-1355)
84. Yamanouchi T, Ogata N, Tagaya T, Kawasaki T, Sekino N, Funato H, Akaoka L & Miyashita H 1996 Clinical usefulness of serum 1,5-anhydroglucitol in monitoring glycaemic control. Lancet 347 1514-1518. (doi:10.1016/S0140-6736(96)90672-8)
85. Yin P, Peter A, Franken H, Zhao X, Neukamm SS, Rosenbaum L, Lucio M, Zell A, Haring HU, Xu G et al. 2013 Preanalytical aspects and sample quality assessment in metabolomics studies of human blood. Clinical Chemistry 59 833-845. (doi:10.1373/clinchem.2012.199257)